Neutralizing Antibody-Mediated Treatment Strategy towards Cure of HIV-1 Infection (Representative: Shuzo Matsushita, Clinical Retrovirology) was selected for FY2019 AMED Research Program on HIV/AIDS.
Category: News & Topics(EN)
Selection for FY2019 AMED Research Program on HIV/AIDS
Creation of New Druggable Targets to Overcome HIV-1 Latency via Collaboration between High-Resolution Nucleic Acid Analyses and Leading-Edge Techniques for Viral Dynamics (Representative: Yorifumi Satou, Genomics and Transcript
